Sign inLaunch App
BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·
BIOMASON
BioMason
Biotechnology · Durham, North Carolina · United States · Founded · 2012 · ≈ · 125 · employees

BioMason competitors

Private

BioMason has 6 close competitors: Atomwise, Colossal Biosciences, Ecovativa Design.

ProfileValuationFundingCompetitorsStock & IPOHow to invest
Peer set

Who competes with BioMason

Sector, valuation and status for each competitor.

company profileBioMason›
Founded 2012United States
competitorAtomwise›
$320Mlatest valuation
Founded 2012Private
competitorColossal Biosciences›
$25Bas of Jul 2026
Founded 2021Private
competitorEcovativa Design›
$130Mas of Dec 2025
Founded 2007Private
competitorFormation Bio›
$1.7Bas of Jun 2024
Founded 2016Private
competitorHalda Therapeutics›
$250Mlatest valuation
competitorInsitro›
$2.4Bas of Sep 2021
Founded 2013Acquired
Head-to-head

BioMason and its peers, side by side

A private valuation and a public market cap share one column; each row names its basis and date.

Company
Sector
Founded
Valuation / market cap
Status
HQ
On Canborsa
BioMason
Biotechnology
2012
no figure
PRIVATE
United States
Company profile
Atomwise
Biotechnology / AI drug discovery
2012
$320M
PRIVATE
United States
Company profile
Colossal Biosciences
Biotechnology
2021
$25Brumored · Jul 2026
PRIVATE
United States
Company profile
Ecovativa Design
Biotechnology / Materials
2007
$130MDec 2025
PRIVATE
United States
Company profile
Formation Bio
Biotechnology / Drug discovery
2016
$1.7BJun 2024
PRIVATE
United States
Company profile
HTHalda Therapeutics
Biotechnology
$250M
PRIVATE
United States
Company profile
Insitro
Biotechnology
2013
$2.4BSep 2021
ACQUIRED
United States
Company profile
Context · reading the peer set

Where BioMason meets its rivals

What BioMason sells, and where the rivals meet it

Biotech company developing sustainable materials using microbial fermentation

BioMason competes with 6 companies here: Atomwise, Colossal Biosciences, Ecovativa Design, Formation Bio, Halda Therapeutics, Insitro.

BioMason on Canborsa
MarketClosest: SP500-PERP
Fees0.07% per side · 0.14% round-trip
Fundingevery 1h

BioMason competitors — frequently asked questions

How can I get exposure to BioMason?›

The routes section explains what is realistically available for a company at this stage.

Is BioMason publicly traded?›

No. BioMason is a private company; its shares do not trade on a public exchange.

Who has invested in BioMason?›

Lead investors for each round are in the funding timeline.

Who are BioMason's competitors?›

The closest biotechnology peers are on the competitors page.

Keep exploring
More in Biotechnology
Life Biosciences competitorscompetitors›NantOmics valuationvaluation›Orbital Therapeutics profilecompany · profile›Ecovativa Design vs Atomwisecompare · versus›All companiesdirectory›
Learn
Stock perps vs tokenized stocksconcept›RWA perpetualsmarkets · index›Perpetuals vs futuresconcept›What is a perpetual?guide · perpetuals basics›All Learn guideslearn · index›
Listed on Canborsa
Cerebras Systems (CBRS)US equity · perp›ChangXin Memory Technologies (CXMT)Asian equity · perp›SpaceX (SPCX)US equity · perp›AMD (AMD)US equity · perp›All 86 marketsindex›
Index · Perpetual · 30x

Trade SP500-PERP on Canborsa

S&P 500 · the Canborsa market closest to BioMason
SpaceXAnthropicBitgetBinanceBlueVineAll companies ›
© Canborsa 2026TermsPrivacy